AI 4 IMMUNO-ONCOLOGY : ADVANCING CANCER CARE THROUGH AI
Few tickets left

AI 4 IMMUNO-ONCOLOGY : ADVANCING CANCER CARE THROUGH AI

By Future4care

Co-organized between Future4care and PSCC, this event will deepdive in how AI transforms cancer research, therapy design and treatment

Date and time

Location

Future4care

8 Rue Jean Antoine de Baïf 75013 Paris France

Good to know

Highlights

  • 5 hours, 15 minutes
  • Ages 18+
  • In person
  • Doors at 8:45 AM

About this event

Science & Tech • Biotech

AI4Immuno-Oncology: Advancing Cancer Care Through AI

Co-organized by Future4care and the Paris Saclay Cancer Cluster

From data to patient outcomes: What if AI could reshape the entire value chain of immuno-oncology?

AI is no longer just optimizing algorithms—it’s fundamentally redefining how we understand disease, design smarter immunotherapies, and personalize treatment at scale.

From uncovering new biological insights to engineering targeted therapies, predicting patient response, and enabling in silico trials, the convergence of AI and immuno-oncology is ushering in a new era of precision, speed, and impact in cancer care.

What to Expect

• Real-world use cases across the R&D and clinical spectrum

• Insights from leading voices in science, biotech, and AI-driven innovation

• A shared vision of the future of immuno-oncology innovation

Agenda Highlights

Opening KeynoteAI & Immuno-Oncology: Major Applications & Upcoming Revolutions

Confirmed speaker: Pr. Philippe Moingeon

Overview of AI & Immuno-Oncology MabDesign Presentation

Panel 1From Disease Models to Targets

Confirmed speakers: Amazigh Mokhtari - Computational biologist Sanofi ; Simon Istolainen - Co-founder Cure51 ; Simon Turner - Partner Sofinnova ; Vincent Bouget - CEO Scienta Lab Moderator: Vassili Soumelis - Chief Medical Officer Owkin

Panel 2Designing the Next Generation of Therapies

Confirmed speakers: Lucia Cinque - Co-founder WhiteLab Genomics ; Thierry Dorval - Head of Data Sciences & Data Management Servier ; Yann Gaston-Mahé - CEO Iktos ; Zakaria Omahdi - Scientific Business Developer MAbSilico Moderator : Pr. Philippe Moingeon

Inspiring KeynoteThe Impact of AI on CAR-T Cell Therapy in Oncology

Confirmed speakers: Pascale Bouillé - Ariana Pharma

Panel 3Data-Driven Precision Medicine

Confirmed speakers: Etienne Formstecher - CEO GMT Science ; Jean-Philippe Vert - Co-founder Bioptimus ; Julien Vibert - Assistant Professor Gustave Roussy Institute, Eric Letouzé - Head of Single-cell One Biosciences ; Reinhard Meier - Founding partner YZR Capital

Welcome coffee from 8:45 AM | Networking lunch at 12:30 PM

Spots are limited – register now to secure your seat!

Organized by

Future4care

Followers

--

Events

--

Hosting

--

Free
Sep 16 · 8:45 AM GMT+2